Hritvik Jain, Andrew M. Goldsweig/LinkedIn
Oct 29, 2025, 07:09
Hritvik Jain and Andrew Goldsweig Shared Risk About the Risk of MACCE, AMI, and readmission in IBD patients undergoing PCI
Hritvik Jain, Founding President of EnigmaMed Research Initiative, shared a post on X:
“In our latest publication in The Canadian Journal of Cardiology (CJC), we report risk of MACCE, AMI, and readmission in IBD patients undergoing PCI! Thanks to Andrew M. Goldsweig guidance and mentorship”
Title: Outcomes of Percutaneous Coronary Intervention in Patients with Inflammatory Bowel Disease: A Propensity-Score Matched Analysis
Authors: Hritvik Jain, Nandan Patel, Jyoti Jain, Kriti Soni, Siddharth P. Agrawal, Bala Pushparaji, Richard Malone, Mohammed Absar Ullah, Andrew M. Goldsweig
Read full article here.
Stay informed with Hemostasis Today.
-
Aug 9, 2026, 14:23Retheesh Das։ Edema Is a Sign, Not a Diagnosis
-
Aug 9, 2026, 13:56Binay Shah: Building a Future of Accessible Cancer Care
-
Aug 9, 2026, 13:44Taking Charge of Your Bleeding Disorder – National Bleeding Disorders Foundation
-
Aug 9, 2026, 13:17Andrew Zapfel: Building a Stronger Future for Sickle Cell Care in Kenya
-
Aug 9, 2026, 13:07Angelica Varesi: New Insights into Hematopoietic Stem Cell Biology
-
Aug 9, 2026, 12:48Paul Watton։ New Clues to the Cause of ME/CFS
-
Aug 9, 2026, 12:26Mohamed Rawy: When Is a Reduced DOAC Dose Appropriate?
-
Aug 9, 2026, 11:22Saqib Ullah: Why Do Red Blood Cells Autoagglutinate
-
Aug 9, 2026, 11:06Oumayma Mnafe: ThroLy and IMPEDE VTE Scores in Hematologic Malignancies